Clinical trials: Advanced Dementia

Alzheimer Disease

Study of Azeliragon in Patients With Mild Alzheimer's Disease and Impaired Glucose Tolerance

• Terminated
• Age: 50 to 85 years
• Phase 2
• Results posted

This is a study to evaluate the efficacy and safety of azeliragon in patients with mild Alzheimer's disease and impaired glucose tolerance.

Trial name

Elevage (NCT03980730)

Testing

Azeliragon

Where

33 sites in United States, Canada

Volunteers

43 people

Sponsor

vTv Therapeutics